- Home
- QBTS vs FENC Comparison
QBTS vs FENC Comparison
Compare QBTS & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- FENC
- Stock Information
- Founded
- QBTS 1999
- FENC 1996
- Country
- QBTS Canada
- FENC United States
- Employees
- QBTS N/A
- FENC N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QBTS Technology
- FENC Health Care
- Exchange
- QBTS Nasdaq
- FENC Nasdaq
- Market Cap
- QBTS 1.4B
- FENC 156.9M
- IPO Year
- QBTS N/A
- FENC 2001
- Fundamental
- Price
- QBTS $5.83
- FENC $6.65
- Analyst Decision
- QBTS Strong Buy
- FENC Strong Buy
- Analyst Count
- QBTS 6
- FENC 2
- Target Price
- QBTS $6.38
- FENC $14.00
- AVG Volume (30 Days)
- QBTS 98.8M
- FENC 58.2K
- Earning Date
- QBTS 03-27-2025
- FENC 03-20-2025
- Dividend Yield
- QBTS N/A
- FENC N/A
- EPS Growth
- QBTS N/A
- FENC N/A
- EPS
- QBTS N/A
- FENC N/A
- Revenue
- QBTS $9,424,000.00
- FENC $49,348,000.00
- Revenue This Year
- QBTS $4.86
- FENC $170.43
- Revenue Next Year
- QBTS $64.04
- FENC $6.70
- P/E Ratio
- QBTS N/A
- FENC N/A
- Revenue Growth
- QBTS 14.27
- FENC 278.09
- 52 Week Low
- QBTS $0.75
- FENC $3.96
- 52 Week High
- QBTS $11.41
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- QBTS 47.95
- FENC 66.40
- Support Level
- QBTS $5.39
- FENC $6.30
- Resistance Level
- QBTS $6.39
- FENC $6.64
- Average True Range (ATR)
- QBTS 0.78
- FENC 0.29
- MACD
- QBTS -0.12
- FENC 0.06
- Stochastic Oscillator
- QBTS 56.47
- FENC 90.23
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company's LeapTM cloud service.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.